Liraglutide improves adipose tissue remodeling and mitochondrial dynamics in a visceral obesity model induced by a high-fat diet

• Main Authors: Vanessa Touceda (Author), Florencia Fontana Estevez (Author), Leonardo Cacciagiú (Author), Paola Finocchietto (Author), Romina Bustos (Author), Agustina Vidal (Author), Gabriela Berg (Author), Celina Morales (Author), Germán González (Author), Veronica Miksztowicz (Author)
• Format: Book
• Published: Elsevier, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Central obesity is characterized by visceral adipose tissue (VAT) expansion, considered one of the main risk factors for metabolic complications. In recent years, new drugs have been studied for obesity treatment. Liraglutide (LGT), a GLP-1 agonist, decreases body weight, however, several mechanisms...